10-Years Follow-up of the EXAMINATION Trial
NCT04462315
Cardiovascular Diseases, Heart Disease
Seriate, Bergamo, Italy
View Trial DetailsNCT Number: NCT02201264
The proposed study is a registry of patients treated with primary angioplasty for acute myocardial infarction.
The aim of this registry is to define the outcomes of patients treated for acute, ST-segment myocardial infarction (STEMI) at community hospitals without on-site cardiac surgery programs that have completed the Cardiovascular Patient Outcomes and Research Team (C-PORT) Primary Angioplasty Development program. The primary medical outcome for the registry is the combined incidence of death, recurrent non-fatal myocardial infarction and stroke.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Community Health and Wellness Center, Bryan, Ohio, United States
The primary study endpoint is the composite incidence of death, non-fatal reinfarction and stroke 6 weeks after index myocardial infarction.
Secondary endpoints include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 weeks after myocardial infarction
The primary study endpoint is the composite incidence of death, non-fatal reinfarction and stroke 6 weeks after index myocardial infarction.
Secondary endpoints include:
Johns Hopkins University
Other
The Atlantic CPORT Primary PCI Registry
Acronym: CPORT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04462315
Cardiovascular Diseases, Heart Disease
Seriate, Bergamo, Italy
View Trial DetailsNCT01423929
Cardiovascular Diseases, Heart Diseases
Helsingborg, Sweden
View Trial DetailsNCT01136187
Cardiovascular Diseases, Heart Diseases
Hradec Králové, Czechia
View Trial DetailsNCT06227754
Cardiovascular Diseases, Heart Diseases
Daegu, South Korea
View Trial Details